Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Tecan Group Ltd sells automated laboratory instruments and solutions for the diagnostics and life science research markets. The firm operates in two segments: Life sciences and Partnering. The life sciences business contributes to the majority of revenue. It sells laboratory instruments and automated workflow solutions to pharmaceutical and biotechnology companies, diagnostic laboratories, and scientists in applied markets. The largest product group in this segment is the scalable liquid handling platforms. The partnering business develops and manufactures OEM instruments and components that Tecan's partner companies then sell under their own names. The largest proportion of Tecan's revenue is generated in Europe and North America.